Skip to main content

Sacrosidase Pregnancy and Breastfeeding Warnings

Brand names: Sucraid

Medically reviewed by Last updated on Sep 26, 2023.

Sacrosidase Pregnancy Warnings

Animal studies have not been conducted. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if clearly needed.

US FDA pregnancy category: C

See references

Sacrosidase Breastfeeding Warnings

The manufacturer makes no recommendation regarding use during lactation.

Excreted into human milk: Unknown
Excreted into animal milk: Unknown

Comment: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. Product Information. Sucraid (sacrosidase). Orphan Medical. 2001.

References for breastfeeding information

  1. Product Information. Sucraid (sacrosidase). Orphan Medical. 2001.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.